Beximco Pharmaceuticals Limited (AIM:BXP)
London flag London · Delayed Price · Currency is GBP · Price in GBX
37.00
-1.88 (-5.08%)
Jun 27, 2025, 4:35 PM GMT+1

Beximco Pharmaceuticals Market Cap

Beximco Pharmaceuticals has a market cap or net worth of 231.99 million as of June 27, 2025. Its market cap has decreased by -42.47% in one year.

Market Cap
231.99M
Enterprise Value
276.14M
Revenue
309.11M
Ranking
n/a
PE Ratio
5.47
Stock Price
37.00

Market Cap Chart

Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 22.96M to 231.99M, an increase of 910.32%. That is a compound annual growth rate of 9.50%.

History

DateMarket Cap% Change
Jun 18, 2025231.99M-4.30%
Dec 30, 2024242.42M-48.09%
Dec 28, 2023466.99M-11.21%
Dec 29, 2022525.95M-29.56%
Dec 30, 2021746.62M1.29%
Dec 30, 2020737.12M192.11%
Dec 30, 2019 Pro Pro
Dec 27, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 157.30B
GSK plc 56.46B
Haleon 33.93B
Smith & Nephew 9.63B
ConvaTec Group 5.90B
Hikma Pharmaceuticals 4.41B
HUTCHMED (China) 1.89B
Oxford Nanopore Technologies 1.30B
Market Cap Rankings